Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry W Grigsby

Showing results (161-170 of 190) with videos related to

Pageof 19
Sort By:
Clinical Nuclear Medicine|July 1, 2011
ACR-ASTRO practice guideline for the performance of therapy with unsealed radiopharmaceutical sourcesRobert E Henkin, John D Del Rowe, Perry W Grigsby, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 29, 2024
Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiationVictoria Shi, Surbhi Grover, Yi Huang, et al.
JCI Insight|July 13, 2021
HPV transcript expression affects cervical cancer response to chemoradiationFiona J Ruiz, Matthew Inkman, Ramachandran Rashmi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 13, 2020
Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancerJessika Contreras, Amar Srivastava, Anupama Chundury, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiationVictoria Shi, Surbhi Grover, Yi Huang, et al.
Biochemical and Biophysical Research Communications|February 20, 2007
Anti-apoptotic peptides protect against radiation-induced cell deathKevin W McConnell, Jared T Muenzer, Kathy C Chang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 9, 2017
Association of post-treatment positron emission tomography with locoregional control and survival after radiation therapy for squamous cell carcinoma of the vulvaYuan James Rao, Comron Hassanzadeh, Anupama Chundury, et al.
Gynecologic Oncology|May 10, 2022
Management and prognosis of cervical cancer patients treated with definitive radiation therapy who have partial metabolic response on post-therapy positron emission tomographyTyler R Mckinnish, Molly M Greenwade, Ivy Wilkinson-Ryan, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
SCCA1/SERPINB3 promotes suppressive immune environment via STAT-dependent chemokine production, blunting the therapy-induced T cell responsesLiyun Chen, Victoria Shi, Songyan Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|November 17, 2018
Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix CancerAlexander J Lin, Elizabeth Kidd, Farrokh Dehdashti, et al.
Pageof 19

Showing results (161-170 of 190) with videos related to

Sort By:
Pageof 19
Clinical Nuclear Medicine|July 1, 2011
ACR-ASTRO practice guideline for the performance of therapy with unsealed radiopharmaceutical sourcesRobert E Henkin, John D Del Rowe, Perry W Grigsby, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 29, 2024
Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiationVictoria Shi, Surbhi Grover, Yi Huang, et al.
JCI Insight|July 13, 2021
HPV transcript expression affects cervical cancer response to chemoradiationFiona J Ruiz, Matthew Inkman, Ramachandran Rashmi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 13, 2020
Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancerJessika Contreras, Amar Srivastava, Anupama Chundury, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiationVictoria Shi, Surbhi Grover, Yi Huang, et al.
Biochemical and Biophysical Research Communications|February 20, 2007
Anti-apoptotic peptides protect against radiation-induced cell deathKevin W McConnell, Jared T Muenzer, Kathy C Chang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 9, 2017
Association of post-treatment positron emission tomography with locoregional control and survival after radiation therapy for squamous cell carcinoma of the vulvaYuan James Rao, Comron Hassanzadeh, Anupama Chundury, et al.
Gynecologic Oncology|May 10, 2022
Management and prognosis of cervical cancer patients treated with definitive radiation therapy who have partial metabolic response on post-therapy positron emission tomographyTyler R Mckinnish, Molly M Greenwade, Ivy Wilkinson-Ryan, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
SCCA1/SERPINB3 promotes suppressive immune environment via STAT-dependent chemokine production, blunting the therapy-induced T cell responsesLiyun Chen, Victoria Shi, Songyan Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|November 17, 2018
Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix CancerAlexander J Lin, Elizabeth Kidd, Farrokh Dehdashti, et al.
Pageof 19